Evidence map›Paper›PMID 36786840›Full record

ArticleActa neuropathologica2023

SMARCA4-associated schwannomatosis.

Fiona Chan-Pak-Choon, Carla Roca, Anne-Sophie Chong, Clara Nogué, Sonja Dahlum, Rachel Austin, Helen Mar Fan, Karin Y van Spaendonck-Zwarts, Neil K Lambie, Thomas Robertson and 3 more

Abstract readLetter
PubMed Publisher
In one paragraph

Article in Acta neuropathologica, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Review
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Fiona Chan-Pak-ChoonDepartment of Human Genetics, McGill University, Montreal, QC, Canada.ORCID 0000-0002-6317-1822
Carla RocaMolecular Mechanisms and Experimental Therapy in Oncology Program, Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, Barcelona, Spain.
Anne-Sophie ChongDepartment of Human Genetics, McGill University, Montreal, QC, Canada.
Clara NoguéMolecular Mechanisms and Experimental Therapy in Oncology Program, Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, Barcelona, Spain.
Sonja DahlumInstitute of Human Genetics, Ulm University and Ulm University Medical Centre, Ulm, Germany.
Rachel AustinGenetic Health Queensland, Royal Brisbane and Women's Hospital, Herston, QLD, Australia.
Helen Mar FanGenetic Health Queensland, Royal Brisbane and Women's Hospital, Herston, QLD, Australia.
Karin Y van Spaendonck-ZwartsGenetic Health Queensland, Royal Brisbane and Women's Hospital, Herston, QLD, Australia.
Neil K LambieAnatomical Pathology, Canterbury Health Laboratories, Christchurch, New Zealand.
Thomas RobertsonPathology Queensland, Faculty of Medicine, Royal Brisbane and Women's Hospital, Herston, QLD, Australia.
Reiner SiebertInstitute of Human Genetics, Ulm University and Ulm University Medical Centre, Ulm, Germany.
Barbara RiveraLady Davis Institute and Segal Cancer Centre, Jewish General Hospital, Montreal, QC, Canada.
William D FoulkesDepartment of Human Genetics, McGill University, Montreal, QC, Canada. william.foulkes@mcgill.ca.ORCID 0000-0001-7427-4651

Funding

CIHR FDN-148390
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

NeurilemmomaNeurofibromatosesSkin NeoplasmsDNA HelicasesHumansNuclear ProteinsTranscription FactorsDNA HelicasesNuclear ProteinsSMARCA4 protein, humanTranscription FactorsBRG1Chromosome 22qSchwannomatosisSMARCA4SWI/SNF

Identifiers

PMID36786840

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.